
OSTEOPETRORICKETS IN AN INFANT WITH COEXISTENT
CONGENITAL CYTOMEGALOVIRUS INFECTION Katsafiloudi M, Gombakis N, Hatzipantelis E, Tragiannidis A *Corresponding Author: Athanasios Tragiannidis, M.D., Ph.D., Assistant Professor of Pediatrics, Pediatric
Hematology-Oncology Unit, 2nd Pediatric Department, AHEPA Hospital, Aristotle University of
Thessaloniki, S. Kiriakidi 1 str., Thessaloniki, Greece. Tel: +306-944-944-777. Fax: +302-310-994-803.
E-mail: atragian@ auth.gr; atragian@hotmail.com page: 107
|
CASE PRESENTATION
A full-term 2 and a half-month-old female, the second
child of consanguine parents with an uneventful perinatal
and neonatal history, was admitted to our clinic due to
hepatosplenomegaly, pallor and petechiae noted by their
pediatrician at routine check. Upon admission, the infant
was afebrile, in a good general condition. Physical examination
showed mild growth retardation, hepatosplenomegaly,
slightly enlarged anterior fontanelle, abnormal eye
movements, mild hypertonia of low extremities. Sporadic
petechiae in head, neck and lower abdomen were also
noticed. Laboratory findings demonstrated leukocytosis
[white blood cell (WBC): 41,350 × 109/L], normocytic
normochromic anemia [hemoglobin (Hb) 7.5 g/dL, packed
cell volume (PCV) 0.24 L/L, mean corpusucular volume
(MCV) 86.9 fL, mean corpuscular Hb (MCH) 28.4 pg, reticulocytes
11.37%] and thrombocytopenia [platelet (PLT)
count 46,000 × 109/L]. Coagulation exams, direct and
indirect Coombs tests were negative. Serology revealed
high levels of alkaline phosphatase (ALP) 1290.0 U/L,
lactate dehydrogenase (LDH) 1003.0 U/L, lactic acid (18.0
mmol/L) and ferritin (241.0 ng/mL). Serum calcium (Ca)
was in lower limits at 8.2 mg/dL and phosphorus (P) under
normal range 2.3 mg/dL, with a Ca × P product of less than
20. Vitamin 25-OH-D level was also low (21.3 ng/mL) and
parathyroid hormone was elevated (17.7 pmol/L). Due to
high levels of thyroid-stimulating hormone (TSH) (14.10
μIU/mL) indicative of hypothyroidism, the patient was
put on levothyroxine therapy. Blood and urine cultures
were sterile, stool culture showed normal flora. Infection
control was negative for hepatitis B virus (HBV), hepatitis
C virus (HCV), hepatitis A virus (HAV), syphilis, rubella,
Ebstein Barr virus (EBV) and toxoplasma.
The CMV DNA was detected in urine and blood and
ganciclovir was administered for 21 days. Metabolic control
with measurement of organic acids in urine and amino
acids in blood and urine was also negative. Abdominal
ultrasound evidenced hepatosplenomegaly, heart and brain
ultrasonography were normal. Small, grayish papillae
and bilateral optic hypoplasia were noted in fundoscopy.
Visual and auditory evoked potentials showed absence of
waveform (blindness) and conductive hearing loss, respectively.
Due to persistent anemia, thrombocytopenia and
leukocytosis, a bone marrow aspiration was performed,
which excluded leukemia and revealed T and NK cells
immunophenotypic disorders. The karyotype was normal.
Radiological findings [osteosclerotic elements in X-rays
with “bone within bone” appearance (Figure 1), marked
sclerosis within the skull base (Figure 2), narrowing of
cranial foramina in brain computed tomography (CT) scan]
raised the suspicion of osteopetrosis, which was finally confirmed by bone biopsy and molecular diagnostics. The
latter revealed a TCIRG1 gene mutation in a homozygous
state, while both parents were found to be heterozygotes
for the same allele. Pathology findings were consistent
with diagnosis of osteopetrosis. Prominence of the costochondral
junctions (rachitic rosary) in chest radiograms
(Figure 3), along with low calcium and phosphate levels
in serum indicated superimposed rickets.
During hospitalization, the infant remained in good
clinical condition and was treated with ganciclovir, ceftazidime
due to E. coli urinary infection, vitamin D3, levothyroxine
and red blood cell (RBC) transfusions. Three
months after initial admission, the infant successfully
underwent BMT with father being the HLA-compatible
donor. Two years later, she remains alive, in a good general
condition.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|